Leo Wealth, LLC
Source: SEC Form 13F · as of Mar 2026Leo Wealth, LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $73.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$73.9M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 171,116 | $41.8M |
| BIIBBIOGEN INC. | 22,737 | $4.2M |
| BMYBRISTOL MYERS SQUIBB CO | 65,938 | $4.0M |
| ABBVAbbVie Inc. | 16,154 | $3.5M |
| LLYELI LILLY & Co | 3,398 | $3.1M |
| MRKMerck & Co., Inc. | 24,749 | $3.0M |
| PFEPFIZER INC | 104,084 | $2.9M |
| NVSNovartis AG | 15,866 | $2.4M |
| SNYSanofi | 38,079 | $1.8M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 28,737 | $1.6M |
| GILDGILEAD SCIENCES, INC. | 9,048 | $1.3M |
| ABTABBOTT LABORATORIES | 10,155 | $1.0M |
| PMPhilip Morris International Inc | 6,062 | $1.0M |
| AMGNAMGEN INC | 1,863 | $656K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,405 | $380K |
| GMOptec International, Inc. | 4,028 | $300K |
| CAHCardinal Health Inc. | 1,310 | $277K |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 3,088 | $269K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 584 | $261K |
| FATEFATE THERAPEUTICS INC | 70,439 | $85K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.